Clinical trial · Interventional
USG Brachial Plexus Block for Upper Extremity Surgery
Ultrasound-guided Brachial Plexus Block With the Single-penetration Multiple-injection-technique for Upper Extremity Surgery
NCT01993290CI-TRIAL-00018583completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Ultrasound-guided (USG) brachial plexus (BP) block efficacy at the Supraclavicular (SCL), Lateral- Infraclavicular (LIC) and Axillary (AX) level: Randomized, observer-blinded study of the single-penetration multiple-injection-technique.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carpal Tunnel Syndrome | — | UNRESOLVED | — |
| Fracture at Wrist and/or Hand Level | — | UNRESOLVED | — |
| Ganglion Cysts | — | UNRESOLVED | — |
| Injuries to the Wrist, Hand and Fingers (S60-S69) | — | UNRESOLVED | — |
| Rupture of Tendon of Wrist and Hand | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ropivacaine | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- USG Supraclavicular block
- description
- 20 ml of ropivacaine 0,75% is administered to brachial plexus at supraclavicular level.
- interventionNames
- Drug: Ropivacaine
- type
- ACTIVE_COMPARATOR
- label
- Lateral infraclavicular block
- description
- 20 ml of ropivacaine 0,75 % is administered to brachialis plexus at lateral infraclavicular level
- interventionNames
- Drug: Ropivacaine
- type
- ACTIVE_COMPARATOR
- label
- USG Axillaris block
- description
- 20 ml of ropivacaine 0,75% is administered to plexus brachialis at axillaris level
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age above 18 years * American Society of Anaesthesiology class 1-3 * Patients undergoing upper extremity surgery Exclusion Criteria: * Inability to cooperate * Inability to understand and talk danish * Allergic to ropivacaine * Infection at site of surgery * Neurological dysfunction at site of surgery * Severe coagulopathy * Drug and alcohol abuse * Patients, who can not get a nerve block due to technical difficulty * Pregnancy or nursing * Body mass index \>35
References
Publications (3)
- BACKGROUNDKoscielniak-Nielsen ZJ, Frederiksen BS, Rasmussen H, Hesselbjerg L. A comparison of ultrasound-guided supraclavicular and infraclavicular blocks for upper extremity surgery. Acta Anaesthesiol Scand. 2009 May;53(5):620-6. doi: 10.1111/j.1399-6576.2009.01909.x. PMID 19419356
- BACKGROUNDMariano ER, Sandhu NS, Loland VJ, Bishop ML, Madison SJ, Abrams RA, Meunier MJ, Ferguson EJ, Ilfeld BM. A randomized comparison of infraclavicular and supraclavicular continuous peripheral nerve blocks for postoperative analgesia. Reg Anesth Pain Med. 2011 Jan-Feb;36(1):26-31. doi: 10.1097/AAP.0b013e318203069b. PMID 21455085
- BACKGROUNDTran DQ, Munoz L, Zaouter C, Russo G, Finlayson RJ. A prospective, randomized comparison between single- and double-injection, ultrasound-guided supraclavicular brachial plexus block. Reg Anesth Pain Med. 2009 Sep-Oct;34(5):420-4. doi: 10.1097/AAP.0b013e3181ae733a. PMID 19920418